Literature DB >> 20344995

[Lithium and chronic kidney disease: a pathology which remains relevant].

Paula Félix1, Catherine Stoermann-Chopard, Pierre-Yves Martin.   

Abstract

Lithium continues to be the standard for acute and maintenance treatment of bipolar mood disorders despite the availability of alternative agents. Lithium has a narrow therapeutic index and can result in considerable toxicity. Acute renal intoxication is well-known but chronic kidney disease should be in each doctor's mind. The main manifestations are nephrogenic diabetes insipidus (NDI) and tubulointerstitial nephritis. For NDI, the potassium sparing diuretic amiloride or a thiazide diuretic can improve polyuria. Lithium-induced ESRD in chronic tubulointerstitial nephritis is not uncommon and more prevalent (> 1% among long-term lithium patients) than previously thought. The risk of renal failure may persist even after lithium discontinuation. Additional kidney manifestations of lithium exposure include renal tubular acidosis and hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20344995

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  1 in total

1.  Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms.

Authors:  Naveen Manohar Pai; Vidhyavathi Malyam; Manisha Murugesan; Sundarnag Ganjekar; Sydney Moirangthem; Geetha Desai
Journal:  Int Clin Psychopharmacol       Date:  2022-01-01       Impact factor: 1.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.